# Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions

> **NCT05090449** · PHASE1 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Chlorthalidone (HIGROTON® 50)
- **DRUG:** Losartan (COZZAR®)
- **DRUG:** A1+ A2 Co-administration of Chlorthalidone and Losartan
- **DRUG:** Chlorthalidone + Losartan Fixed-Dose combination

## Key facts

- **NCT ID:** NCT05090449
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-04-08
- **Final completion:** 2020-05-25
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05090449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05090449, "Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05090449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*